With a view to push its bulk drugs and immuno-suppressant products overseas, RPG Life Sciences is eyeing marketing and distribution tie-ups with foreign companies.The RPG Group company is eyeing the European market for both its bulk drugs and immuno-suppressants
The company has recently inked a co-operation pact with Poland's Polpharma, to develop and manufacture Active Pharmaceutical Ingredients (APIs) and in the management of the supply-chain of selected high-value APIs like clopidogrel bisulphate. The tie-up will help the RPG Group company push its products in Europe. Both the companies will buy products from each other and sell them in their respective strong markets. RPG is in in talks for marketing tie-ups for selling its products in Germany, Greece and Poland and expects some tie-ups to fructify over the next three-months.
crackcrack